Skip to content
Aperlena
Language:

Belgium - Research and experimental development services - Clinical Trial Readiness through the Establishment of a Pilot Filovirus Investigational Vaccine Reserve

Upcoming Prior information notice No deadline published
Watch this tender

We email you if the deadline moves or a correction is published. Free. Log in

Summary

Machine-generated summary

The buyer, located in Belgium, is procuring research and experimental development services to advance clinical trial preparedness for Filovirus outbreaks in the EU and globally. The contract covers establishing, piloting and maintaining an investigational reserve of Filovirus candidate vaccines against Marburg (MARV) and/or Ebola Sudan (SUDV), including preparation of phase 2 and/or phase 2/3 clinical trial activities. Subject to conditions such as an outbreak and the contracting authority's consent, the reserved vaccine doses may also be used in clinical trials.

Description

This call for tenders aims to advance the clinical trial preparedness and readiness for Filovirus outbreaks within the European Union and globally as a critical preparedness measure, given the sporadic yet high-consequence nature of these pathogens. Specifically, the call aims to establish, pilot and maintain an investigational reserve of Filovirus candidate vaccines against Marburg (MARV) and/or Ebola Sudan (SUDV) to support such preparedness. Readiness for phase 2 and/or phase 2/3 clinical trials of Filovirus vaccines will be ensured through the advance preparation of key clinical trial activities, including the establishment of an EU-based reserve of those investigational vaccines. Subject to specific conditions being met (such as the occurrence of an outbreak and the expressed consent of the Contracting Authority), this call for tenders also provisions for the use of the reserved investigational vaccine candidates to enable clinical trials up to the number of doses held in reserve.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago

View the official notice

More from this buyer

Full buyer profile

5 open tenders right now

Who usually wins this buyer's contracts in this sector

Company Wins Total awarded Last win
PREDICTBY RESEARCH AND CONSULTING S.L.; EUROPEAN BLOOD ALLIANCE; EEBA; ESHRE; EUROPEAN HEMATOLOGY ASSOCIATION; EUROPEAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION; EHMSG; European Association of Tissue and Cell Banks, EATCB; EMBA 1 €3.5M Mar 2026
KPMG ADVISORY LIMITED; KPMG 1 €2.0M Jul 2026
VERIAN GROUP BELGIUM 1 €900,250 Jan 2026
AGENCE DE LA BIOMEDECINE 1 n/a Feb 2026
NIVI Development P/S; ETHRIS; SSI; VISMEDERI SRL; ECRAID; BAVARIAN NORDIC; EVO; IDT; SANOFI R&D VACCINS; SVA 1 n/a Dec 2025

Based on 5 awards with a linked company profile over the last 5 years.

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

  1. Read before bidding
    • Estimated value: Set to €16,000,000
    • Estimated value: Set to €16,000,000

Follow this tender and we email you the moment it changes. Create account

Similar tenders

Market context

Avg. open tender · Research & development
€3,264,378
532 open across Europe right now 390% above sector average
Buyer track record on Aperlena
31 notices tracked · 10 awarded
€19,708,560 in awarded contracts

Never miss a tender like this

7 new notices in Research & development in Belgium in the last 7 days. Get an email when new ones appear. Free.

Set up my alert
Source

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Jump to the search box
?
Show these shortcuts
Esc
Close